Document is current
Any future updates will be listed below
-
Authors
Perez-Brumer, Amaya https://orcid.org/0000-0003-2441-4358
Schmidt, Rose
Kennedy, Rebecca
Lake, Jordan E.
Villarreal, Yolanda R.
Bornstein, Sydney
Kuo, Irene
Nieto, Omar
Franks, Julie
Denis, Cecile
El-Bassel, Nabila
Shoptaw, Steve
Davidson, Peter
Smith, Laramie R.
-
Funding
Funding for this research was provided by:
Foundation for the National Institutes of Health (UM1AI068617-15, P30 MH058107, R34 DA059327)
Canadian Institutes of Health Research (CRC-2021-00132)
- License Information
-
More Information
Article History
Received: 29 September 2023
Accepted: 14 November 2024
First Online: 18 December 2024
Declarations
:
: This trial was approved for all sites by a central institutional review board (Advarra), and specific to the implementation science sub-study University of Toronto Research Ethics Board approval was also obtained. All participants provide written informed consent prior to initiation of any study activities. This manuscript’s content is solely the author’s responsibility and does not necessarily represent the official views of the NIH. JEL has receives research support from Gilead Sciences and Zydus and is a consultant to CytoDyn and Theratechnologies.
: None to declare.
